Biacore vitamin test kits receive AOAC R I certification
Biacore International AB announced that its proprietary food analysis kits for routine testing of water soluble vitamins have now been fully validated and certified as a Performance Tested MethodSM, Qflex® Kit Vitamin B2 PI (Certificate No. 010604), Qflex Kit Vitamin B12 PI (Certificate No. 010605), Qflex Kit biotin (Certificate No. 010606) and Qflex Kit Folic acid (Certificate No.080201), by the Association of Analytical Communities Research Institute (AOAC).
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

Stop aging? - Key molecule of aging discovered

BioPAT® MFCS | Process management software | Sartorius
Facio partners with Evotec and initiates FSHD drug discovery programme
Pitt researchers harness carbon nanomaterials for drug delivery systems, oxygen sensors - Researchers describe carbon nanocapsules for drug and energy storage in Advanced Materials, creation of highly sensitive oxygen sensors in Nature Chemistry

How stressed tumor cells escape cell death - New mechanism discovered
Metabolic pathway that drives tumor growth in aggressive cancers
Estonian Genome Project Foundation (EGPF) - Tartu, Estonia

Running on fumes? How fruit flies protect their brains during periods of starvation - Fruit flies stay sharp by flipping a metabolic switch in the brain
Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
Phase III study shows Novartis drug Afinitor more than doubles time without tumor growth in advanced pancreatic NET patients - Everolimus extended median progression-free survival from 4.6 to 11.0 months vs. placebo and reduced risk of cancer progression by 65%
